New patent for the drug Fennec Pharms PEDMARK – DrugPatentWatch
Annual Drug Patent Expiration for PEDMARK
Pedmark is a drug marketed by Fennec Pharms Inc and included in one NDA. It is available from a single supplier. There are three patents protecting this drug.
This drug has thirty-six patent family members in thirteen countries.
The generic ingredient in PEDMARK is sodium thiosulfate. One registered supplier for this compound. Additional details are available on the sodium thiosulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Fennec Pharms PEDMARK
